System and method for rescuing measles viruses and recombinant measles viruses
A measles virus and antigenome technology, applied in the direction of virus, virus/phage, recombinant DNA technology, etc., can solve the problems of difficult to obtain stably, time-consuming and laborious, and complicated preparation process of measles vaccine, and achieves high rescue efficiency, excellent application prospect, good stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0042] Embodiment 1 The present invention rescues measles virus or constructs the recombinant measles virus vector expressing GFP
[0043] 1 Materials and methods
[0044] 1.1 Sources of vectors and strains
[0045] The measles virus Shanghai 191 originated from the Shanghai Institute of Biological Products. pT7-IRES His-C DNA was purchased from Takara Company; the vector pGEM-T was purchased from Promega Company of the United States.
[0046] 1.2 Main reagents
[0047] High-purity viral RNA extraction kit was purchased from Roche; phusion high-fidelity DNA polymerase and T4 DNA ligase were purchased from NEB; random primers, Superscript III reverse transcriptase, cell transfection reagent Lipofectamine TM 2000 was purchased from Invitrogen Company of the United States; gel recovery kit was purchased from Promega Company; plasmid extraction kit was purchased from Omega Company; agarose and DNA marker were purchased from Takara Company; other reagents were domestic reagents....
Embodiment 2
[0097] Example 2 Using the system of the present invention to rescue measles virus and recombinant measles virus expressing GFP
[0098] Rescue measles virus and recombinant measles virus expressing GFP using the vector constructed in Example 1 of the present invention: as Figure 13 As shown, build the rescue system.
[0099] 1 Rescue from the virus
[0100] BSR T7 cells were cultured in a 6-well plate at 37° C. for 24 hours, and transfected when they grew into a single layer and the confluence of the cells was 80%-90%. 12 μg full-length plasmid pT7MV S191 , 12μgpT7MV S191 -ATU-GFP was mixed with helper plasmids 8μg pT7-MV-N, 4μg pT7-MV-P, 1μg pT7-MV-L respectively, added to 100μL DMEM high-glucose culture medium and mixed, and then mixed with 100μL of premixed 10μL Lipofectamine 2000 Reagent Mix the DMEM culture solution evenly, place it at room temperature for 30 minutes, then drop it into a 6-well plate, and place it at 37°C, 5% CO 2 Cultivate in an incubator for 5-18...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com